NCM
VMD icon

Nantahala Capital Management’s Viemed Healthcare VMD Stock Holding History

Nantahala Capital Management’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.14M Sell
883,783
-48,662
-5% -$405K 0.3% 79
2025
Q4 		$6.93M Hold
932,445
– – 0.23% 90
2025
Q3 		$6.33M Hold
932,445
– – 0.22% 96
2025
Q2 		$6.44M Hold
932,445
– – 0.25% 77
2025
Q1 		$6.79M Sell
932,445
-2,677
-0.3% -$21K 0.27% 58
2024
Q4 		$7.5M Sell
935,122
-200,000
-18% -$1.74M 0.32% 57
2024
Q3 		$8.32M Sell
1,135,122
-300,000
-21% -$2.14M 0.42% 49
2024
Q2 		$9.4M Sell
1,435,122
-115,000
-7% -$867K 0.55% 36
2024
Q1 		$14.6M Sell
1,550,122
-402,246
-21% -$3.45M 0.84% 26
2023
Q4 		$15.3M Sell
1,952,368
-79,802
-4% -$579K 0.92% 20
2023
Q3 		$13.7M Buy
2,032,170
+303,675
+18% +$2.49M 1.17% 17
2023
Q2 		$16.9M Buy
1,728,495
+135,701
+9% +$1.38M 1.63% 11
2023
Q1 		$15.4M Sell
1,592,794
-177,206
-10% -$1.54M 1.18% 23
2022
Q4 		$13.4M Sell
1,770,000
-20,505
-1% -$139K 0.87% 29
2022
Q3 		$10.7M Buy
1,790,505
+75,579
+4% +$485K 0.7% 39
2022
Q2 		$9.23M Buy
1,714,926
+421,114
+33% +$2.27M 0.46% 46
2022
Q1 		$6.44M Sell
1,293,812
-129,726
-9% -$602K 0.29% 59
2021
Q4 		$7.43M Sell
1,423,538
-9,663
-0.7% -$53.9K 0.26% 67
2021
Q3 		$7.95M Sell
1,433,201
-267,395
-16% -$1.74M 0.25% 73
2021
Q2 		$12.2M Sell
1,700,596
-229,994
-12% -$1.99M 0.35% 60
2021
Q1 		$19.5M Sell
1,930,590
-20,890
-1% -$197K 0.57% 42
2020
Q4 		$15.2M Buy
1,951,480
+453,380
+30% +$3.99M 0.47% 50
2020
Q3 		$13M Hold
1,498,100
– – 0.4% 58
2020
Q2 		$14.4M Hold
1,498,100
– – 0.43% 50
2020
Q1 		$7.13M Hold
1,498,100
– – 0.27% 60
2019
Q4 		$9.38M Hold
1,498,100
– – 0.29% 51
2019
Q3 		$10.3M Buy
+1,498,100
New +$9.98M 0.38% 51

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Nantahala Capital Management's VMD Position: Q1 2026 in Review

Nantahala Capital Management reduced its Viemed Healthcare (VMD) stake by 5.2% in Q1 2026, selling an estimated $405K and leaving 883,783 shares worth $8.14M. The position accounts for 0.3% of the portfolio, ranked #79.

Nantahala Capital Management first reported a position in VMD in Q3 2019 and has held it in 27 quarters since. The position peaked at $19.5M in Q1 2021. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Nantahala Capital Management held 883,783 shares of Viemed Healthcare worth $8.14M as of Q1 2026.
  • Nantahala Capital Management sold 48,662 Viemed Healthcare shares in Q1 2026, an estimated $405K.
  • Viemed Healthcare made up 0.3% of Nantahala Capital Management's portfolio in Q1 2026, its #79 holding.
  • Nantahala Capital Management first reported a position in Viemed Healthcare in Q3 2019 and has held it in 27 quarters since.
  • Nantahala Capital Management's Viemed Healthcare position peaked at $19.5M in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.